Pediatrix Medical Group
MD
#5219
Rank
NZ$2.13 B
Marketcap
$24.81
Share price
-1.59%
Change (1 day)
76.49%
Change (1 year)

P/E ratio for Pediatrix Medical Group (MD)

P/E ratio as of December 2024 (TTM): 12.6

According to Pediatrix Medical Group's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 12.6112. At the end of 2022 the company had a P/E ratio of 18.6.

P/E ratio history for Pediatrix Medical Group from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202218.64.75%
202117.8-790.09%
2020-2.5867.31%
2019-1.54-113.7%
201811.2-27.59%
201715.5-18.41%
201619.0-4.17%
201519.9-3.31%
201420.57.5%
201319.118.22%
201216.21.61%
201115.92.8%
201015.5-1.37%
200915.781.08%
20088.66-62.51%
200723.111.02%
200620.8-46.43%
200538.8145.76%
200415.82.14%
200315.53.14%
200215.0-38.07%
200124.2

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
19.0 50.51%๐Ÿ‡บ๐Ÿ‡ธ USA
1.75-86.09%๐Ÿ‡บ๐Ÿ‡ธ USA
28.9 129.49%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.